Objectives The impact of rheumatic diseases on COVID-19 infection remains poorly
investigated. Here we performed a systematic review and meta-analysis to evaluate the …

Objectives COVID-19 pandemic has already had a tremendous impact on the process of
human society; the survival of mankind and the healthy living environment deterioration with …

Patients with rheumatic diseases are often more susceptible to different bacteria and viruses
because of immune impairment, but it is not clear whether there is a higher risk of infection …

Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly
understood. The aim was to examine demographic and clinical factors associated with …

This study aimed to assess the baseline characteristics and clinical outcomes of coronavirus
disease 2019 (COVID-19) in patients with rheumatic diseases and identify the risk factors …

Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly
known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with …

Objectives To investigate coronavirus disease 2019 (COVID-19)-associated risk of
hospitalization and death in RA, AS, PsA, SLE and SSc in comparison with the general …

Objective To investigate differences in manifestations and outcomes of coronavirus disease
2019 (COVID-19) infection between those with and without rheumatic disease. Methods We …

Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes
remain a major concern for patients with rheumatic and musculoskeletal diseases. We …

There is concern that people with rheumatic disease, often treated with immunosuppressive
or immunomodulatory medication, may be at an increased risk of poor outcomes of novel …